PHF20 AND JMJD3 COMPOSITIONS AND METHODS OF USE IN CANCER IMMUNOTHERAPY

摘要

Pharmaceutical compositons and methods for regulating somatic cell reprogramming in mammals, and in particular, for positively and negatively regulating cell reprogramming in human cells in vivo and in vitro. The invention also provides PHF20-derived compositions and methods useful for cancer immunotherapies, including breast cancer therapies in particular.